halobetasol propionate 0.5 MG/ML Topical Foam
halobetasol propionate
RxCUI: 2047646
What the CMS Formulary Data Shows for halobetasol propionate 0.5 MG/ML Topical Foam
Per the CMS 2026 Part D formulary file, halobetasol propionate 0.5 MG/ML Topical Foam (RxNorm concept RXCUI 2047646, generic name halobetasol propionate) appears on 2 distinct formulary files spanning 115 Medicare Part D plan offerings - 2.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 4 to Tier 4, with a cross-plan average of Tier 4.
Real-world access to halobetasol propionate 0.5 MG/ML Topical Foam depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 89,868 Part D beneficiaries filled halobetasol propionate 0.5 MG/ML Topical Foam in 2023, with total plan-and-beneficiary spending of $18,442,607 and an average per-beneficiary annual cost of $205.22. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry halobetasol propionate 0.5 MG/ML Topical Foam today.
Coverage Details
- Formularies covering
- 2
- Plans covering
- 115
- Coverage rate
- 2.3%
- Tier range
- Tier 4, Non-Preferred
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 89,868
- Total spending
- $18,442,607
- Avg per beneficiary
- $205.22
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering halobetasol propionate 0.5 MG/ML Topical Foam
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is halobetasol propionate 0.5 MG/ML Topical Foam covered by Medicare Part D?
Yes, halobetasol propionate 0.5 MG/ML Topical Foam is covered by 115 Medicare Part D plans (2.3% of all Part D formularies).
What tier is halobetasol propionate 0.5 MG/ML Topical Foam on Medicare Part D plans?
halobetasol propionate 0.5 MG/ML Topical Foam averages Tier 4 across Part D plans, ranging from Tier 4 to Tier 4.
Does halobetasol propionate 0.5 MG/ML Topical Foam require prior authorization?
0% of Part D formularies require prior authorization for halobetasol propionate 0.5 MG/ML Topical Foam. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on halobetasol propionate 0.5 MG/ML Topical Foam?
In 2023, total Medicare Part D spending on halobetasol propionate 0.5 MG/ML Topical Foam was $18,442,607, covering 89,868 beneficiaries. The average spend per beneficiary was $205.22.
Read our methodology - how this data is sourced, computed, and verified.